1. Adamson JW Correction of thc anicmia of end-stage renal disease with recombinant human crythropoictin;Eschbach, J.W.; Egrie, J.C.; Downing, M.R.; Browne, J.K.;Engl. ViMed,1987
2. Ef'fect of htuman erythropoietin derived from recombinant DNA on the anaemia of patients tnaintaitted by chronic haemodialysis;C(G, Winearls; AIj, P.'ippard; t)owning MR; DO, Oliver; C, Reid; PMN, Cotes;Latncet,1986
3. Canadian Ersthropoietin Study Group. A prospective, randomized, douLble-blind stuLds of recombittant erythropoietin (r-Hu-EPO)0 in chronic hemodialv sis [Abstract]. Kidsne Iti 1988; 33: 218A. 4 Eschbach JVI. 'rhc ancmia ot' chronic renal failure: pathophvsiologv and the effect of recombinant crsthropoietin;Kidnicesv Int,1989
4. Qualits ot' life: subjective and objectise improvements with recombinant htuman crs thropoictin therapy;Ltindin, A.P.;Semin Nephrol,1989
5. Impros-ed sexual funictioni in hcmodialssis patients on rccombinant erythropoietiit: a possible role for prolactin. Clin.\';Schacfer, R.A.M.; Kokot, F.; Wlcrnze, H.; Geiger, H.; Heidland, A.;phrol,1989